Fundz

Pep Gen Inc. reported raising $14.4 Million in an initial SEC Form D filing, from an offering of $51.8 Million

PUBLIC · PEPGDec 09, 2020$14.4M of $51.8M raised

Amount Raised

$14.4 Million

$14.4 Million sold, per SEC Form D (first sale Dec 9, 2020)

Round Type

Venture

BostonBiotechnologyHealthcare

Quick answer

PepGen raised $14.4 Million in a funding round, dated December 9, 2020. PepGen is based in Boston, Massachusetts, United States.

How much did PepGen raise?
PepGen raised $14.4 Million in a funding round on December 9, 2020.
What does PepGen do?
PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases.
Where is PepGen based and how big is it?
PepGen is based in Boston, Massachusetts, United States. Fundz records about 84 employees.
Who are the decision-makers at PepGen?
Fundz holds 3 contacts at PepGen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as PepGen that raised within 45 days of this round, from Fundz verified event records.

  • Turn Medical, LLC raised $500K (Seed) on January 22, 2021.
  • Lakewood-Amedex, Inc. raised $24M on January 22, 2021.
  • Nocion Therapeutics raised $15M on January 22, 2021.
  • Enveric Biosciences raised $13M on January 20, 2021.
  • Optimvia raised $523K on January 20, 2021.
  • Myra Vision raised $5.3M on January 20, 2021.

Who to call at PepGen, and when

A new round usually means PepGen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PepGen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PepGen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PepGen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PepGen

Location

Boston, Massachusetts, United States

About

PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide (EDO) platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PepGen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contacts10 people are listed at PepGen. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PepGen's next move

See what Strategic adds

PepGen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.